AzTrials
AzTrials

Arthritis, RheumatoidNCT03063593

UK Infinity, Post-Market Clinical Follow-up Study

An observational study of Arthritis, Rheumatoid and Post-traumatic Osteoarthritis, run by Stryker Trauma and Extremities at 12 sites in United Kingdom.

Active, not recruiting

Under way, not looking for participants. Everyone needed has enrolled. The study is still running.

Official record
Search all trials

Trial summary

Study Title UK Post-Market Clinical Follow-Up Of The INFINITY® Total Ankle System Study Design Prospective, multi-site, multi-year post-market clinical follow-up study Study Group Primary/Unilateral and/or bilateral Total Ankle Arthroplasty subjects implanted with INFINITY® Total Ankle System Number of Subjects 500… Read more about this study

Who is it for?
Ages 21 years and older
How many people
500 participants
Where
12 sitesUnited Kingdom
Study dates
29 Apr 2016to 31 Dec 2029
Phase
Observational
Are there results?
Not yet: the study is under way

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 21 years and older
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Study population: Primary/Unilateral and/or bilateral Total Ankle Arthroplasty subjects implanted with INFINITY® Total Ankle System

Who may be able to join

  • Subjects to be included in the study must meet all of the following criteria:
  • Be 21 years of age at the time of surgery;
  • Diagnosed with unilateral and/or bilateral ankle joint disease;
  • Diagnosed with ankle joint damage from rheumatoid arthritis, post-traumatic, or degenerative arthritis; Willing and able to consent to participate (written, informed consent / witnessed verbal consent) Willing and able to attend the requested follow-up visits;
  • Subjects determined by the Investigator to be an appropriate candidate for the INFINITY® Total Ankle System

Who cannot join

  • Subjects will be excluded from the study if they meet any of the following criteria:
  • Subjects with an ankle condition, as determined by the investigator, to be an inappropriate candidate for a total ankle replacement;
  • Subjects requiring revision total ankle replacement of the ankle being considered for study

Trial locations and contacts

12 sites in 1 country.

12 sites in 1 country

United Kingdom12 sites
  • University Hairmyres Hospital

    Bothwell, Scotland, G71 8BB

  • Royal Bournemouth Hosptial

    Bournemouth, Dorset, BH7 7DW

  • North Bristol NHS Trust Southmead Hospital

    Bristol, BS105NB

  • Royal Infirmary of Edinburgh

    Edinburgh, EH16 4SA

  • Royal Devon and Exeter NHS Foundation Trust

    Exeter, EX2 5DW

  • Royal National Orthopaedic Hospital

    Middlesex, HA7 4LP

  • North Tyneside General Hospital

    Newcastle upon Tyne, NE29 8NH

  • Nottingham University Hospitals NHS Trust

    Nottingham, United Kingdom, NG5 1PB

  • RJAH Orthopaedic Hospital

    Oswestry, Shropshire, SY10 7AG

  • Sheffield Teaching Hospital

    Sheffield, South Yorksire, S5 7AU

  • Torbay Hospital

    Torquay, Devon, TQ2 7AA

  • Wrightington Hospital

    Wigan, WN6 9EP

Other trials in United Kingdom

About this study

Official title: UK Multi-Centre, Observational, Post-Market Clinical Follow-up of the INFINITY® Total Ankle System

Study Title UK Post-Market Clinical Follow-Up Of The INFINITY® Total Ankle System Study Design Prospective, multi-site, multi-year post-market clinical follow-up study Study Group Primary/Unilateral and/or bilateral Total Ankle Arthroplasty subjects implanted with INFINITY® Total Ankle System Number of Subjects 500 with 10 sites

Read the detailed description

Study Title UK Post-Market Clinical Follow-Up Of The INFINITY® Total Ankle System Study Design Prospective, multi-site, multi-year post-market clinical follow-up study Study Group Primary/Unilateral and/or bilateral Total Ankle Arthroplasty subjects implanted with INFINITY® Total Ankle System N Subjects 500 with 10 sites Follow-Up Schedule Subject enrollment will consist of a Pre-operative, Operative, 6 months, 1 yr., 2 yr., 5yr., 7 yr., 10 yr., and an unscheduled visit as needed.

Primary Objective Evaluate the long-term survivorship of the INFINITY® implant over 10 years

Secondary Objective(s) Secondary objectives assessed will be to:

  • Identify and assess the implant for component loosening and/or subsidence, any osteolysis and/or cyst formation through radiographic evaluation early and throughout the lifetime of the implant.
  • Compare the improvements in self-reported pain and social interaction for quality of life measures from pre-op through 10 years post operatively; assessed by EuroQol (EQ5D5L).
  • Compare pain and functional improvement in the Ankle Osteoarthritis Score (AOS), which is a visual analogue scale specifically designed as a modification of the Foot Function Index.
  • Compare the improvement in self-reported pain-free function scores from pre-op through 10 years post-operatively, assessed by the Manchester Oxford Foot Questionnaire (MOXFQ) walking/standing scores.
  • Identify and report the safety of the implant in terms of complications and adverse events.

Inclusion Criteria Subjects to be included in the study must meet all of the following criteria:

  • Be 21 years of age at the time of surgery;
  • Diagnosed with unilateral and/or bilateral ankle joint disease;
  • Diagnosed with ankle joint damage from rheumatoid arthritis, post-traumatic, or degenerative arthritis; Willing and able to consent to participate (written, informed consent / witnessed verbal consent) Willing and able to attend the requested follow-up visits;
  • Subjects determined by the Investigator to be an appropriate candidate for the INFINITY® Total Ankle System

Exclusion Criteria Subjects will be excluded from the study if they meet any of the following criteria:

  • Subjects with an ankle condition, as determined by the investigator, to be an inappropriate candidate for a total ankle replacement;
  • Subjects requiring revision total ankle replacement of the ankle being considered for study
Medical subject headings
Arthritis, Rheumatoid, Osteoarthritis

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Primary Outcome Measure survivorship at 10 years

    The primary outcome measure of this post-market clinical observational study is to collect data relating to the INFINITY® Total Ankle System performance/survivorship at up to 10 years.

    Measured: 10 Years

Secondary outcomes (4)
  1. EQ5D-EuroQol-questionnaire

    Compare the improvement in self-reported pain and social interaction for quality of life measures

    Measured: From pre-op through 10 years

  2. Ankle Osteoarthritis Score (AOS)-questionnaire

    Self-reported to compare pain and functional improvement, which is a visual analogue scale specifically designed as a modification of the Foot function Index

    Measured: From Pre-op through 10 years

  3. Manchester Oxford Foot Questionnaire (MOXFQ)-questionnaire

    Compare the improvement in self-reported pain-free function scores (walking/standing scores)

    Measured: From Pre-op through 10 years

  4. Radiographic evaluation-physician reported questionnaire

    identify and assess the implant for component loosening and/or subsidence, any osteolysis and/or cyst formation

    Measured: From Pre-op through 10 years

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted24 Feb 2017
  2. Study start29 Apr 2016
  3. Primary completion31 Dec 2029 (estimated)
  4. Study completion31 Dec 2029 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Observational
Observational model
Other
Time perspective
Prospective
Enrolment
500 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT03063593
Sponsor's protocol ID
UK15-TAR-001
Status last verified
Jan 2026
First submitted
15 Feb 2017
Last updated
28 Aug 2026
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No

Questions about this trial

What is this clinical trial studying?

An observational study of Arthritis, Rheumatoid and Post-traumatic Osteoarthritis, run by Stryker Trauma and Extremities at 12 sites in United Kingdom.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 5 inclusion and 3 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: under way, not looking for participants, as of the sponsor's last update on 28 Aug 2026. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 12 sites in United Kingdom. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

This study is still under way. Results are not available in the source record yet.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Primary Outcome Measure survivorship at 10 years (time frame: 10 Years). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 28 Aug 2026.

Free account

Keep searching with a free account

You’ve used your 3 free searches for this session. Log in or create a free AzTrials account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in